Literature DB >> 29056459

Low-flow support of the chronic pressure-overloaded right ventricle induces reversed remodeling.

Tom Verbelen1, Piet Claus2, Daniel Burkhoff3, Ronald B Driesen4, Chandan Kadur Nagaraju4, Erik Verbeken5, Karin Sipido4, Marion Delcroix6, Filip Rega7, Bart Meyns7.   

Abstract

BACKGROUND: Mechanical right ventricular (RV) support in pulmonary arterial hypertension patients has been feared to cause pulmonary hemorrhage and to be detrimental for the after-load-sensitive RV. Continuous low-flow pumps offer promise but remain insufficiently tested.
METHODS: The pulmonary artery was banded in 20 sheep in this study. Eight weeks later, a Synergy micro-pump (HeartWare International, Framingham MA) was inserted in 10 animals, driving blood from the right atrium to the pulmonary artery. After magnetic resonance imaging, hemodynamics and RV pressure-volume loop data were recorded. Eight weeks later, RV function was assessed in the same way, followed by histologic analysis of the ventricular tissue.
RESULTS: During the 8 weeks of support, RV volumes and central venous pressure decreased significantly, whereas RV contractility increased. Pulmonary artery pressure increased modestly, particularly its diastolic component. RV contribution to total right-sided cardiac output increased from 12 ± 12% to 41 ± 9% (p < 1 × 10-4). After pump inactivation, and compared with 8 weeks earlier, RV volumes had significantly decreased, tricuspid valve regurgitation had almost disappeared, and RV contractility had significantly increased, resulting in significantly increased RV forward power (0.25 ± 0.05 vs 0.16 ± 0.06 W, p = 0.014). Fulton index and RV myocyte size were significantly smaller, and without changes in fibrosis, when compared with controls.
CONCLUSIONS: Prolonged continuous low-flow RV mechanical support significantly unloads the chronic pressure-overloaded RV and improves cardiac output. After 8 weeks, RV hemodynamic recovery and reverse remodeling begin to occur, without increased fibrosis.
Copyright © 2018 International Society for the Heart and Lung Transplantation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Pulmonary arterial hypertension; pressure-overloaded right ventricle; right ventricular failure; right ventricular mechanical support

Mesh:

Year:  2017        PMID: 29056459     DOI: 10.1016/j.healun.2017.09.014

Source DB:  PubMed          Journal:  J Heart Lung Transplant        ISSN: 1053-2498            Impact factor:   10.247


  6 in total

1.  Delineating the molecular and histological events that govern right ventricular recovery using a novel mouse model of pulmonary artery de-banding.

Authors:  Mario Boehm; Xuefei Tian; Yuqiang Mao; Kenzo Ichimura; Melanie J Dufva; Khadem Ali; Svenja Dannewitz Prosseda; Yiwei Shi; Kazuya Kuramoto; Sushma Reddy; Vitaly O Kheyfets; Ross J Metzger; Edda Spiekerkoetter
Journal:  Cardiovasc Res       Date:  2020-08-01       Impact factor: 10.787

2.  Impact of reductive tricuspid ring annuloplasty on right ventricular size, geometry and strain in an ovine model of functional tricuspid regurgitation.

Authors:  Artur Iwasieczko; Marcin Malinowski; Monica Solarewicz; Jared Bush; Brian MacDougall; Manuel Rausch; Tomasz A Timek
Journal:  Interact Cardiovasc Thorac Surg       Date:  2022-07-09

3.  Temporary assist device support for the right ventricle: pre-implant and post-implant challenges.

Authors:  Michael Dandel; Roland Hetzer
Journal:  Heart Fail Rev       Date:  2018-03       Impact factor: 4.214

4.  Intensive care, right ventricular support and lung transplantation in patients with pulmonary hypertension.

Authors:  Marius M Hoeper; Raymond L Benza; Paul Corris; Marc de Perrot; Elie Fadel; Anne M Keogh; Christian Kühn; Laurent Savale; Walter Klepetko
Journal:  Eur Respir J       Date:  2019-01-24       Impact factor: 16.671

Review 5.  Right Ventricular Failure: Pathophysiology, Diagnosis and Treatment.

Authors:  Mattia Arrigo; Lars Christian Huber; Stephan Winnik; Fran Mikulicic; Federica Guidetti; Michelle Frank; Andreas J Flammer; Frank Ruschitzka
Journal:  Card Fail Rev       Date:  2019-11-04

6.  First in vivo assessment of RAS-Q technology as lung support device for pulmonary hypertension.

Authors:  Tom Verbelen; Michael Halwes; Bart Meyns
Journal:  Int J Artif Organs       Date:  2020-09-10       Impact factor: 1.595

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.